Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endoscopic diagnosis and management of adult inflammatory bowel disease: a consensus document from the American Society for Gastrointestinal Endoscopy IBD Endoscopy Consensus Panel.
ASGE IBD Endoscopy Consensus Panel; Shen B, Abreu MT, Cohen ER, Farraye FA, Fischer M, Feuerstadt P, Kapur S, Ko HM, Kochhar GS, Liu X, Mahadevan U, McBride DL, Navaneethan U, Regueiro M, Ritter T, Sharma P, Lichtenstein GR. ASGE IBD Endoscopy Consensus Panel, et al. Among authors: feuerstadt p. Gastrointest Endosc. 2024 Oct 18:S0016-5107(24)03472-2. doi: 10.1016/j.gie.2024.08.034. Online ahead of print. Gastrointest Endosc. 2024. PMID: 39425706
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial.
Allegretti JR, Kelly CR, Louie T, Fischer M, Hota S, Misra B, Van Hise NW, Yen E, Bullock JS, Silverman M, Davis I, McGill SK, Pardi DS, Orenstein R, Grinspan A, El-Nachef N, Feuerstadt P, Borody TJ, Khanna S, Budree S, Kassam Z. Allegretti JR, et al. Among authors: feuerstadt p. Gastroenterology. 2024 Oct 2:S0016-5085(24)05536-7. doi: 10.1053/j.gastro.2024.09.030. Online ahead of print. Gastroenterology. 2024. PMID: 39366468
A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States.
Cash BD, Lu M, Lembo A, Feuerstadt P, Nguyen L, Terasawa E, Ayyagari R, Du S, Pi S, Westermeyer B, Terreri B, Boules M, Moshiree B. Cash BD, et al. Among authors: feuerstadt p. J Manag Care Spec Pharm. 2024 Oct;30(10):1136-1148. doi: 10.18553/jmcp.2024.30.10.1136. J Manag Care Spec Pharm. 2024. PMID: 39321115 Free PMC article.
The 3 Ds: Depression, Dysbiosis, and Clostridiodes difficile.
Boustany A, Feuerstadt P, Tillotson G. Boustany A, et al. Among authors: feuerstadt p. Adv Ther. 2024 Nov;41(11):3982-3995. doi: 10.1007/s12325-024-02972-0. Epub 2024 Sep 14. Adv Ther. 2024. PMID: 39276186 Free PMC article. Review.
Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS; ECOSPOR III and ECOSPOR IV investigators. Kraft CS, et al. Among authors: feuerstadt p. Infect Dis Ther. 2024 Oct;13(10):2209-2210. doi: 10.1007/s40121-024-01036-8. Infect Dis Ther. 2024. PMID: 39212853 Free PMC article. No abstract available.
PUNCH CD3-OLS: a phase 3 prospective observational cohort study to evaluate the safety and efficacy of fecal microbiota, live-jslm (REBYOTA) in adults with recurrent Clostridioides difficile infection.
Feuerstadt P, Chopra T, Knapple W, Van Hise NW, Dubberke ER, Baggott B, Guthmueller B, Bancke L, Gamborg M, Steiner TS, Van Handel D, Khanna S. Feuerstadt P, et al. Clin Infect Dis. 2024 Aug 24:ciae437. doi: 10.1093/cid/ciae437. Online ahead of print. Clin Infect Dis. 2024. PMID: 39180326
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, Khanna S, Berenson CS, Wang EEL, Cohen SH, Korman L, Lee C, Kelly CR, Odio A, Cook PP, Lashner B, Ramesh M, Kumar P, De A, Memisoglu A, Lombardi DA, Hasson BR, McGovern BH, von Moltke L, Pardi DS; ECOSPOR III and ECOSPOR IV investigators. Kraft CS, et al. Among authors: feuerstadt p. Infect Dis Ther. 2024 Oct;13(10):2105-2121. doi: 10.1007/s40121-024-01007-z. Epub 2024 Jun 28. Infect Dis Ther. 2024. PMID: 38941068 Free PMC article.
Retrospective subgroup analysis of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infection.
Knapple WL, Yoho DS, Sheh A, Thul J, Feuerstadt P. Knapple WL, et al. Among authors: feuerstadt p. Therap Adv Gastroenterol. 2024 Mar 24;17:17562848241239547. doi: 10.1177/17562848241239547. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38529070 Free PMC article.
75 results